Dermata Therapeutics DRMA
NASDAQ DRMA
$1.42 +0.04 (+2.90%)
At close: Aug 21, 2026 · 4:00 PM EDT

Dermata Therapeutics (DRMA) Amortizatization of Intangibles (2020 - 2021)

Dermata Therapeutics (DRMA) posted quarterly Amortizatization of Intangibles of $155.0 for Q3 2021, down 99.04% year-over-year from $16134.0 in Q3 2020, and up 98.72% quarter-over-quarter from $78.0 in Q2 2021.

Dermata Therapeutics (DRMA) Amortizatization of Intangibles (2020 - 2021) Analysis & Trends

Dermata Therapeutics' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $155.0 for Q3 2021.

  • In Q3 2021, Amortizatization of Intangibles fell 99.04% year-over-year to $155.0; the TTM figure through Jun 2022 stood at $155.0 (down 99.6% YoY), while the FY2021 annual figure was $14126.0, down 85.45% from the prior year.
  • Amortizatization of Intangibles for Q3 2021 stood at $155.0, up from $78.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $16134.0 in Q3 2020, with the low at $78.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Dermata Therapeutics 5.40 Mn 5.40 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 155.00
Sep 30, 2021 155.00
Jun 30, 2021 78.00
Jun 30, 2021 78.00
Mar 31, 2021 13,892.00
Mar 31, 2021 13,892.00
Dec 31, 2020 8,811.00
Dec 31, 2020 8,811.00
Sep 30, 2020 16,134.00
Sep 30, 2020 16,134.00